Deepdive – Oncology 2021

As experts from the Institute of Cancer Research, Lucid Group, and Syneos Health discuss in this issue, funding gaps, paused trials and patients’ health anxiety will have reverberations impacting outcomes for years to come.

But it’s perhaps a testament to the sector’s strength that even among these challenges, all of our contributors see the huge potential for cancer research going forward. In this year’s ASCO roundup we look at the next generation of exciting cancer immunotherapies, Olivia Kersey from Prime Global tells us how patient insights can vastly improve oncology research, and speakers from ICON demonstrate how cell and gene therapy trials are becoming ever more sophisticated.